One major BCR-ABL1 downstream signaling pathway that plays a role in proliferation, survival, and drug resistance in CML is the JAK/STAT signaling pathway, and its important effectors are STAT3 and STAT5 [114]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.